Microscopic anatomy of the human islet of Langerhans

Advances in Experimental Medicine and Biology

Volumn 654, Issue , 2010, Pages 1-19

  In't Veld, Peter ^a   Marichal, Miriam ^b  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b NONE

Author keywords

cell; cell; cell; Amyloid; Anatomy; Autoimmunity; Innervation; Insulitis; Morphology; Non endocrine cells; Pathology; PP cell; Type 1 diabetes; Type 2 diabetes; Vasculature

Indexed keywords

AMYLIN; AUTOANTIBODY; C PEPTIDE; GHRELIN; GLUCAGON; HLA DQ ANTIGEN; INSULIN; NEUROGENIN 3; PANCREAS POLYPEPTIDE; PROINSULIN; SOMATOSTATIN; TRANSCRIPTION FACTOR; ZINC; AMYLOID; GLUCOSE;

ACINAR CELL; ARTICLE; AUTOIMMUNITY; CAPILLARY; CAPILLARY BASEMENT MEMBRANE; CELL COMPOSITION; CELL DESTRUCTION; CELL DIFFERENTIATION; CELL DIVISION; CELL REGENERATION; CELL SIZE; CELL TYPE; CELLULAR DISTRIBUTION; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CYTOARCHITECTURE; ENDOCRINE CELL; FETUS DEVELOPMENT; GLUCAGON RELEASE; HUMAN; INFLAMMATORY INFILTRATE; INNERVATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULITIS; ISLET CAPILLARY; ISLET VASCULATURE; MICROSCOPIC ANATOMY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS; PANCREAS ACINUS; PANCREAS ISLET; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET AMYLOID DEPOSITION; PANCREAS ISLET BETA CELL; PANCREAS ISLET BETA CELL MASS; PANCREAS ISLET CELL; PANCREAS ISLET DELTA CELL; PANCREAS ISLET EPSILON CELL; PRIMORDIUM; PRIORITY JOURNAL; SCHWANN CELL; SECRETORY GRANULE; SOMATOSTATIN RELEASE; VASCULARIZATION; ANIMAL; AUDIOVISUAL EQUIPMENT; BIOLOGICAL MODEL; CYTOLOGY; HISTOLOGY; HOMEOSTASIS; INFLAMMATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVIEW; ULTRASTRUCTURE;

AMYLOID; ANIMALS; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GLUCOSE; HOMEOSTASIS; HUMANS; INFLAMMATION; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MODELS, ANATOMIC; MODELS, BIOLOGICAL;

EID: 77953920802     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-90-481-3271-3_1     Document Type: Article

References (111)

1. Ogilvie RF. A quantitative estimation of the pancreatic islet tissue. Quart J Med 1937; 6:287-300.
2. Volk BW, Wellman KF. Historical review. In: Volk BW, Arquilla ER, editors. The diabetic pancreas. New York: Plenum; 1985: p. 1-16.
3. Hellman B, Hellerström C. Histology and histophysiology of the islets of Langerhans in man. In Pfeiffer EF, editor. Handbook of diabetes mellitus. Munich: Lehmanns, V; 1969: p. 90-118.
4. Goldstein MB, Davis EA. The three dimensional architecture of the islets of Langerhans. Acta Anat 1968;71:161-71.
5. Hughes SJ, Clark A, McShane P, Contractor HH, Gray DW, Johnson PR. Characterisation of collagen VI within the islet exocrine interface of the human pancreas: implications for clinical islet isolation? Transplantation 2006;81:423-6. (Pubitemid 43255730)
6. Smith PH. Structural modification of Schwann cells in the pancreatic islet of the dog. Am J Anat 1975;144:513-7.
7. Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC. Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes, Obesity and Metabolism 2008;10 Suppl 4: 32-42.
8. Pictet R, Rutter WJ. Development of the embryonic endocrine pancreas. In: Steiner DF, Freinkel N, editors. Handbook of Physiology. Section 7: Endocrinology. Vol. 1: Endocrine pancreas. Baltimore: Williams & Wilkins; 1972. p. 25-66.
9. Edlund H. Pancreatic organogenesis-developmental mechanisms and implications for therapy. Nature Rev Gen 2002;3:524-32. (Pubitemid 34746877)
10. Bencosme SA, Liepa E. Regional differences of the pancreatic islet. Endocrinology 1955;57: 588-93.
11. Orci L, Malaisse-Lagae F, Baetens D, Perrelet A. Pancreatic-polypeptide- rich regions in human pancreas. Lancet 1978;ii:1200-1.
12. Murtaugh LC. Pancreas and beta-cell development: from the actual to the possible. Development 2007; 134:427-38. (Pubitemid 46332480)
13. Stefan Y, Grasso S, Perrelet A, Orci L. A quantitative immunofluorescent study of the endocrine cell populations in the developing human pancreas. Diabetes 1983;32:293-301. (Pubitemid 13161899)
14. Xu X, D Hoker J, Stangé G, Bonné S, De Leu N, Xiao X, Van De Casteele M, Meelitzer G, Ling Z, Pipeleers D, Bouwens L, Scharfmann R, Gradwohl G, Heimberg H. Beta cells can be generated from endogeneous progenitors in injured adult mouse pancreas. Cell 2008;132:197-207. (Pubitemid 351181232)
15. Kassem SA, Ariel I, Thornton PS, Scheimberg I, Glaser B. Beta cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 2000;49:1325-33. (Pubitemid 30624233)
16. Meier JJ, Butler AE, Saisho Y, Monchamp T, Galasso R, Bhushan A, Rizza RA, Butler PC. Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes 2008;57:1584-94.
17. Bouwens L, Lu WG, De Krijger R. Proliferation and differentiation in the human fetal pancreas. Diabetologia 1997;40:398-404. (Pubitemid 27132610)
18. Rahier J, Wallon J, Henquin JC. Cell populations in the endocrine pancreas of human neonates and infants. Diabetologia 1981;20:540-6. (Pubitemid 11096949)
19. Orci L, Stefan Y, Malaisse-Lagae F, Perrelet A. Instability of pancreatic endocrine cell population throughout life. Lancet 1979;1:615-6. (Pubitemid 9136410)
20. Clark A, Grant AM. Quantitative morphology of endocrine cells in human fetal pancreas. Diabetologia 1983;25:31-5. (Pubitemid 13070125)
21. Like AA, Orci L. Embryogenesis of the human fetal pancreatic islets: a light and electron microscopic study. Diabetes 1972;21:511-34.
22. Lane MA. The cytological characteristics of the areas of Langerhans. Am J Anat 1907; 409-22.
23. Bloom W. A new type of granular cell in the islets of Langerhans of man. Anat Record 1931;49: 363-71.
24. Kimmel JR, Pollock HG, Hazelwood RL. A new pancreatic polypeptide. Fed Proc (USA) 1971; 30:1318 (abstr).
25. Wierup N, Svensson H, Mulder H, Sundler F. The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Reg Peptides 2002;107:63-9. (Pubitemid 34876446)
26. Murlin JR, Clough HG, Gibbs CB, Stokes AM. Aqueous extracts of pancreas. I. Influence on the carbohydrate metabolism of depancreatized animals. J Biol Chem 1923;56:253.
27. Bell GI, Santere RF, Mullenbach GT. Hamster preproglucagon contains the sequence of glucagons and two related peptides. Nature 1983;302:716-8. (Pubitemid 13120276)
28. Vaillant CR, Lund PK. Distribution of glucagons-like peptide I in canine and feline pancreas and gastrointestinal tract. Histochem Cytochem 1986;34:1117-21. (Pubitemid 16044841)
29. Deconinck JF, Potvliege PR, Gepts W. The ultrastructure of the human pancreatic islets. I. The islets of adults. Diabetologia 1971;7:266-82.
30. Baum J, Simmons BE, Unger RH, Madison LL, Localization of glucagon in the A-cells in the pancreatic islet by immunofluorescence. Diabetes 1962:11;371-4.
31. Stefan Y, Orci L, Malaisse-Lagae F, Perrelet A, Patel Y, Unger RH. Quantitation of endocrine cell content in the pancreas of non-diabetic and diabetic humans. Diabetes 1982;31: 694-700. (Pubitemid 12095166)
32. Rahier J, Goebbels RM, Henquin JC. Cellular composition of the human diabetic pancreas. Diabetologia 1983;24:366-71. (Pubitemid 13092224)
33. Brissova M, Fowler MJ, Nicholson WE, Chu A, Hirshberg B, Harlan DM, Powers AC. Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cytochem 2005;53:1087-97. (Pubitemid 41262977)
34. Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO, Caicedo A. The unique cytoarchitecture of human pancreatic islets has implications for islet function. Proc Natl Acad Sci USA 2006;103:2334-9. (Pubitemid 43271670)
35. Banting FG, Best CH. The internal secretion of the pancreas. J Lab Clin Med 1922; 7: 465-80.
36. Bliss M. The discovery of insulin. University of Chicago Press, 1982.
37. Orci L. The insulin cell: its cellular environment and how it processes (pro)insulin. Diabetes Metab Rev 1986; 2:71-106. (Pubitemid 16079235)
38. Johnson KH, O Brien TD, Hayden DW, Jordan K, Ghobrial HKG, Mahoney WC, Westermark P. Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase-antiperoxidase (PAP) and protein A-gold techniques. Am J. Pathol 1988;130:1-8. (Pubitemid 18044828)
39. Lacy PE. Electron microscopic and fluorescent antibody studies on islets of Langerhans. Exp Cell Res 1959;7:296-308.
40. Maske H. Interaction between insulin and zinc in the islets of Langerhans. Diabetes 1957;6:335-341.
41. Olofsson CS, Göpel SO, Barg S, Galvanovskis J, Ma X, Salehi A, Rorsman P, Eliasson L. Fast insulin secretion reflects exocytosis of docked granules in mouse pancreatic beta cells. Pflugers Arch 2002;444:43-51. (Pubitemid 34499244)
42. Dean PM, Ultrastructural morphometry of the pancreatic beta cell. Diabetologia 1973;9:115-119.
43. Eliasson L, Abdulkader F, Braun M, Galvanovski J, Hoppa MB, Rorsman P. Novel aspects of the molecular mechanisms controlling insulin secretion. J Physiol 2008;586:3313-24. (Pubitemid 352003868)
44. Eiden LE. Is chromogranin-A a prohormone? Nature 1987;325:301.
45. Hutton JC, Peshavaria M, Johnston CF, Ravazzola M, Orci L. Immunolocalization of betagranin: a chromogranin A-related protein of the pancreatic B-cell. Endocrinology 1988;122:1014-20. (Pubitemid 18082060)
46. Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, Rewers M, Eisenbarth GS, Jensen J, Davidson HW, Hutton JC. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci (USA) 2007;104:17040-5. (Pubitemid 350210987)
47. Lan MS, Wasserfall C, Maclaren NK, Notkins L. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci (USA) 1996;93:6367-70. (Pubitemid 26230311)
48. Baekkeskov S, Aanstoor HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P. Identification of the 64 k autoantigen in insulindependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990;347:151-6.
49. Schuit F, In't Veld PA, Pipeleers DG. Glucose recruits pancreatic B-cells to proinsulin biosynthesis. Proc Natl Acad Sci USA 1988;85:3865-9.
50. Ehrie MG, Swartz FJ. Diploid, tetraploid and octaploid beta cells in the islets of Langerhans of the normal human pancreas. Diabetes 1974;23:583-8.
51. Cnop M, Grupping A, Hoorens A, Bouwens L, Pipeleers-Marichal M, Pipeleers D. Endocystosis of low density lipoprotein by human pancreatic B-cells and uptake in lipid-storing vesicles which accumulate with age. Amer J Pathol 2000;156:237-44. (Pubitemid 30644457)
52. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973;179:77-9.
53. Luft R, Efendic S, Hökfelt T, Johansson O, Azimura A. Immunohistochemical evidence for the localization of somatostatin-like immunoreactivity in a cell population of the pancreatic islets. Med Biol 1974;52:428-30.
54. Bloom SR, Polak JM. Somatostatin. Br Med J 1987;295:288-9. (Pubitemid 17118555)
55. Grube D, Bohn R. The microanatomy of human islets of Langerhans with special reference to somatostatin (D-) cells. Arch Histol Jap 1983;46:327-53. (Pubitemid 13051487)
56. Larsson LI, Sundler F, Hakansson R, Pollock HG, Kimmel JR. Localization of APP, a postulated new hormone to a pancreatic endocrine cell type. Histochemistry 1974;42: 377-82.
57. Watanabe T, Yaegashi H, Koizumi M, Toyota T, Takahashi T. Changing distribution of islets in the developing human pancreas: a computer-assisted three-dimensional reconstruction study. Pancreas 1999;18:349-54. (Pubitemid 29203307)
58. Wittingen J, Frey CF. Islet concentration in the head, body, tail and uncinate process of the pancreas. Ann Surg 1974;179:412-4.
59. Saito K, Takahashi T, Yagginuma B, Iwama N. Morphometrical analysis on topographical difference in size distribution, number and volume of islets in the human pancreas. Tohoku J exp Med 1978;124:177-86. (Pubitemid 8292550)
60. Orci L, Baetens D, Ravazzola M, Stefan Y, Malaisse-Lagae F. Pancreatic polypeptide and glucagon: non-random distribution in pancreatic islets. Life Sci 1976;19:1811-5. (Pubitemid 8013725)
61. Klimstra DS, Hruban RH, Pitman MR. In: Histology for Pathologists, 3rd ed. Stacey E Mills, editor. Lippincott, Wiliams & Wilkins 2007.
62. Bouwens L, Pipeleers DG. Extra-insular beta cells associated with ductules are frequent in adult human pancreas. Diabetologia 1998;41:452-9.
63. Dor Y, Brown J, Martinez OI, Melton D. Adult pancreatic beta-cells are formed by selfduplication rather than stem-cell differentiation. Nature 2004;429:41-6. (Pubitemid 38620543)
64. Gomori G. A differential stain for cell types in the pancreatic islets; Am J Pathol 1939;15:497-9.
65. Grimelius L, Strand A. Ultrastructural studies of the argyrophil reaction in alpha1 cells in human pancreatic islets. Virchows Arch A Pathol Anat Histol 1974;364:129-35.
66. Hellerström C, Hellman B. Some aspects of silver impregnation of the islets of Langerhans in the rat, Acta endocrinol (Copenh.) 1960;35:518-32.
67. de Koning EJ, van den Brand JJ, Mott VL, Chargé SB, Hansen BC, Bodkin NL, Moris JF, Clark A. Macrophages and pancreatic islet amyloidosis. Amyloid 1998;5:247-54. (Pubitemid 128690763)
68. O Morchoe CC. Lymphatic system of the pancreas. Micros Res Tech 1997;37:456-77. (Pubitemid 27294884)
69. Jansson L, Carlsson PO. Graft vascular function after transplantation of pancreatic islets. Diabetologia 2002;45:749-63.
70. Ballian N. Islet vasculature as a regulator of endocrine pancreas function. World J Surg 2007;31:705-14. (Pubitemid 46496227)
71. Zanone MM, Favaro E, Camussi G. From endothelial to beta cells: insights into pancreatic islet microendothelium. Curr Diabetes Rev 2008;4:1-9. (Pubitemid 351210967)
72. Zanone MM, Favaro E, Doublier S, Lozanoska-Ochser B, Deregibus MC, Greening J, Huang GC, Klein N, Cavallo Perin P, Peakman M, Camussi G. Expression of nephrin by human pancreatic islet endothelial cells. Diabetologia 2005;48:1789-97. (Pubitemid 41317833)
73. Henderson JR, Moss MC. A morphometric study of the endocrine and exocrine capillaries of the pancreas. Q J Exp. Physiol 1985;70:347-56. (Pubitemid 15070871)
74. Lammert E, Gu G, McLaughlin M, Brown D, Brekken R, Murtaugh LC, Gerber HP, Ferrara N, Melton DA. Role of VEGF-A in vascularization of pancreatic islets. Current Biology 2003;13:1070-4. (Pubitemid 36726045)
75. Bonner-Weir S. Morphological evidence for pancreatic polarity of beta cell within islets of Langerhans. Diabetes 1988;37:616-21.
76. Virtanen I, Banerjee M, Palgi J, Korsgren O, Lukinius A, Thornell LE, Kikkawa Y, Sekiguchi K, Hukkanen M, Konttinen YT, Otonkoski T. Blood vessels of human islets of Langerhans are surrounded by a double basement membrane. Diabetologia 2008;51:1181-91.
77. Koma Y, Furuno T, Hagiyama M, Hamaquchi K, Nakanishi M, Masuda M, Hirota S, Yokozaki H, Ito A. Cell adhesion molecule 1 is a novel pancreatic-islet cell adhesion molecule that mediates nerve-islet cell interactions. Gastroenterology 2008;134:1544-54. (Pubitemid 351615356)
78. Ahrén B. Regulation of insulin secretion by nerves and neuropeptides. Ann Acad Med Singapore 1999;28:99-104.
79. Tsui H, Winer S, Chan Y, Truong D, Tang L, Yantha J, Paltser G, Dosch HM. Islet glia, neurons, and beta cells. Ann NY Acad Sci 2008;1150-32-42.
80. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965;14:619-33.
81. Löhr M, Klöppel G. Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia 1987;30:757-62. (Pubitemid 17163000)
82. Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS: The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20-years of age in the United Kingdom. Diabetologia 1986;29:267-74. (Pubitemid 16080921)
83. Pipeleers D, Ling Z. Pancreatic cells in insulin-dependent diabetes. Diabetes Metabolism Reviews 1992;8:209-27.
84. Roep BO. The role of T-cells in the pathogenesis of type 1 diabetes: from cause to cure. Diabetologia 2003;46:305-21. (Pubitemid 36547585)
85. Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PGF, Gamble DR. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. New Eng J Med 1985;313:353-60. (Pubitemid 15046367)
86. Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 2008;155:173-81.
87. Bingley PJ, Bonifacio E, Gale EAM: Can we really predict IDDM? Diabetes 1993;42:213-20. (Pubitemid 23045023)
88. In t Veld P, Lievens D, De Grijse J, Ling Z, Van Der Auwera B, Pipeleers-Marichal M, Gorus F, Pipeleers D. Screening for insulitis in adult autoantibody-positive organ donors. Diabetes 2007;56:2000-4.
89. Butler AE, Galasso R, Meier JJ, Basu R, Rizza RA, Butler PC. Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of ketoacidosis. Diabetologia 2007;50:2323-31. (Pubitemid 47512399)
90. Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC. Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration. Diabetologia 2005;48:2221-28. (Pubitemid 41618910)
91. Dotta F, Censini S, van Halteren AGS, Marselli L, Masini M, Dionisi S, Mosca F, Boggi U, Muda AO, Del Prato S, Elliott JF, Covacci A, Rappuoli R, Roep BO, Marchetti P. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent onset type 1 diabetic patients. Proc Natl Acad Sci 2007;104:5115-20. (Pubitemid 47186185)
92. Ahrén B, Thorsson O. Increased insulin sensitivity is associated with reduced insulin and glucagon secretion and increased insulin clearance in man. J Clin Endocrinol Metab 2003;88:1264-70. (Pubitemid 36337788)
93. Cerasi E, Ktorza A. Anatomical and functional plasticity of pancreatic beta-cells and type 2 diabetes. Med Sci (Paris) 2007;23:885-94. (Pubitemid 350003975)
94. Parsons JA, Brelje TC, Sorenson RL. Adaptations of islets of Langerhans to pregnancy; increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion. Endocrinol 1992;130:1459-66.
95. Edström K, Cerasi E, Luft R. Insulin response to glucose infusion during pregnancy. A prospective study of high and low insulin responders with normal carbohydrate tolerance. Acta Endocrinol. 1974;75:87-104.
96. Westermark P, Wilander E, Westermark GT, Johnson KH. Islet amyloid polypeptide-like immunoreactivity in the islet B cells of type 2 (non-insulin-dependent) diabetic and nondiabetic individuals. Diabetologia 1987;30:887-92. (Pubitemid 18003672)
97. Opie E. The relation of diabetes mellitus to lesions of the pancreas. Hyaline degeneration of the islands of Langerhans. J Exp Med 1901;5:527-40.
98. Clark A, Saad MF, Nezzer T, Uren C, Knowler WC, Bennett PH, Turner RC. Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians. Diabetologia 1990; 33:285-9. (Pubitemid 20161883)
99. Westermark P. Fine structure of islets of Langerhans in insular amyloidosis. Virchows Arch A Patol Anat 1973;359:1-18.
100. Butler PC, Chou J, Carter WB, Wang YN, Bu BH, Chang D, Chang JK, Rizza RA. Effects of meal ingestion on plasma amylin concentration in NIDDM and non-diabetic humans. Diabetes 1990;39:752-56. (Pubitemid 20218978)
101. Sanke T, Hanabusa T, Nakano Y, Oki C, Bishimura S, Kondo M, Nanjo K. Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (noninsulin- dependent) diabetic patients. Diabetologia 1991;34:129-32.
102. Maloy AL, Longnecker DS, Greenberg ER. The relation of islet amyloid to the clinical type of diabetes. Human Pathol 1981;12:917-22. (Pubitemid 12227621)
103. Zhao HL, Lai FM, Tong PC, Zhong DR, Yang D, Tomlinson B, Chan JC. Prevalence and clinicopathological characteristics of islet amyloid in Chinese patients with type 2 diabetes. Diabetes 2003;52:2759-66. (Pubitemid 37339705)
104. Clark A, Nilsson MR. Islet amyloid: a complication of islet dysfunction or an aetiological factor in type 2 diabetes. Diabetologia 2004;47:157-69. (Pubitemid 38315352)
105. Borromeo CM, Pottier X, In t Veld PA, Pipeleers-Marichal MA, Kaufman L, Pipeleers DG, Van Schravendijk CF. Heterogeneity in distribution of amyloid-positive islets in type-2 diabetic patients. Virchows Arch 2005;446:232-8. (Pubitemid 40558377)
106. Clark A, Wells CA, Buley ID, Cruickshank JK, Vanhegan RI, Matthews DR, Cooper GJ, Holman RR, Turner RC. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 1988;9:151-9. (Pubitemid 19105415)
107. Sempoux C, Guiot Y, Dubois D, Moulin P, Rahier J. Human type 2 diabetes: morphological evidence for abnormal beta-cell function. Diabetes 2001;50 Suppl:S172-7. (Pubitemid 32148247)
108. Klöppel G, Löhr M, Habich K, Oberholzer M, Heitz PU. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res 1985;4:110-25.
109. Butler AE, Janson J, Soeller WC, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003;52:102-10. (Pubitemid 36042113)
110. Haataja L, Gurlo T, Huang CJ, Butler PC. Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocr Rev 2008;29:303-16. (Pubitemid 351679701)
111. Janson J, Laedtke T, Parisi JE, O Brien P, Petersen RC, Butler PC. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 2004;53:474-81. (Pubitemid 38174565)